FDA Proposes Requiring Unit-Dose Packaging For Orally Disintegrating OTC Monograph Drugs

Separate Proposal Would Make Change Easier To Swallow

 
• By Malcolm Spicer
  
CDER Office of Nonprescription Drugs' proposed order for individual packaging requirements for would establish OTC monograph condition B001. (Source: FDA/Citeline)

More from Policy & Regulation

More from HBW Insight